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DNA repair: The Nijmegen breakage syndrome protein
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The gene mutated in Nijmegen breakage syndrome, a
chromosome instability disorder, has been identified
and sequenced. The protein product of this gene forms
a complex with hMre11 and hRad50 — proteins that are
involved in repairing double-strand breaks in DNA.
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Nijmegen breakage syndrome (NBS), an autosomal reces-
sive disease [1], is a relatively rare disorder with only about
70 affected families worldwide. The key clinical features
of NBS include stunted growth; microcephaly (abnormally
small head); respiratory infections due, most probably, to
the immunodeficiency caused by immune system defects;
and predisposition to cancer at an early age, particularly to
leukaemia, lymphoma, haemoblastoma or neuroblastoma.
Some striking clinical and, especially, cellular similarities
to the autosomal recessive disease ataxia telangiectasia
(AT) have led NBS to be classified as a variant of AT;
however, NBS patients have neither ataxia (lack of muscu-
lar coordination) nor telangiectasia (abnormal vasodila-
tion), and AT patients do not have microcephaly.
The similarities in the characteristics of cells from NBS
and AT patients nonetheless suggest that the defective
functions in both diseases might be related. In particular,
both NBS and AT cells display chromosomal instability,
most notably of chromosomes 7 and 14 [2,3] where the
genes for immunoglobulins and T-cell receptors are
located. Also, in both conditions the cells are hypersensi-
tive to ionizing radiation, their chromosomes have high
levels of radiation-induced chromosome fragility, and
DNA replication is not delayed in response to ionizing
radiation like it is in normal cells [2]. This cell-cycle
checkpoint defect may be due, in part, to a delayed and
reduced induction of the checkpoint tumour suppressor
protein p53 in response to irradiation [4,5]. 
The defective gene in AT, ATM, maps to chromosome
11q23 and encodes a member of the phosphatidylinositol-
3 kinase family that is related to the catalytic subunit of
DNA-dependent protein kinase (DNA–PKcs) — a protein
involved in DNA double-strand-break repair and in
recombination of the V(D)J regions of immunoglobulin
and T-cell receptor genes, which generates antibody and
antigen receptor diversity [6]. The product of the ATM
gene appears to be involved in signalling DNA damage to
p53 [6]. Mapping of the gene affected in NBS — termed
NBS1 — to a 1 centimorgan region on chromosome 8q21
[7] and, by a method of chromosome transfer involving
cell fusion, to chromosome 8q21–24 [8] strongly suggested
that NBS1 was distinct from ATM.
This conclusion is now unequivocal since the chromoso-
mal mapping location of the NBS1 gene was confirmed
recently by positional cloning [9,10]. Nevertheless, the
phenotypic similarities between the two diseases, and the
lack of complementation for radiation-induced chromoso-
mal aberrations in NBS–AT cell fusions [11], suggest that
the two gene products may work closely in the same bio-
chemical pathway, and perhaps even in the same protein
complex [11]. In an unrelated study, Petrini and col-
leagues [12] identified the protein encoded by the NBS1
gene as a component of a complex that is implicated in
repairing the DNA double-strand breaks that are induced
by DNA-damaging agents and that occur naturally during
meiotic recombination. These findings provide a frame-
work within which the molecular basis of NBS might be
explained as a defect in signalling and/or repairing DNA
double-strand breaks.
The NBS1 protein
The NBS1 gene encodes a polypeptide of 754 amino acids
with a predicted molecular mass of 85 kDa that Varon et
al. [9] named nibrin, and Petrini and colleagues [12] call
NBS1. Most cases of NBS are due to a common founder
mutation in NBS1. The mutation, 657del5, is a 5 base pair
deletion that results in premature truncation of the
protein product 15 amino acids downstream of the dele-
tion site [9,10]. Overall, NBS1 has no striking primary
sequence similarity to previously characterized proteins.
It has two recognizable domains, however, within the
amino-terminal 200 amino acids: one forkhead-associated
(FHA) domain and one breast cancer carboxy-terminal
(BRCT) domain (Figure 1). Both types of domain have
been found individually in a variety of proteins but they
have never before been found adjacent to each other
within the same protein. 
The BRCT domain was first identified in the carboxyl ter-
minus of the breast cancer susceptibility protein BRCA1
[13] and, to date, has been found in over 40 other proteins
that function predominantly in DNA repair and DNA
damage checkpoints [14]. On structural grounds, the BRCT
domain is expected to be involved in protein–protein inter-
actions, and this seems to be the case for the domains in
DNA ligase III [15] and poly(ADP-ribose) polymerase [16]
that bind to XRCC1, and the domain in DNA ligase IV that
binds to XRCC4 [17].
The FHA domain was originally identified in a subset of
the forkhead family of transcription factors, and has subse-
quently been found in around 20 unrelated proteins [18].
Like NBS1, all but one of the characterized FHA-contain-
ing proteins are nuclear, and most of the uncharacterized
proteins contain putative bipartite nuclear localization
signals. Four of the FHA-domain-containing proteins are
yeast protein kinases that are involved in meiotic recombi-
nation and respond to signals related to DNA replication
and repair. As yet, there is no known function for FHA
domains. There is a hint, however, that the domains might
mediate interactions with phosphoproteins: the FHA-
domain-containing kinase-associated protein phosphatase
(KAPP) from Arabidopsis thaliana interacts with its target
kinase only when the kinase is autophosphorylated on
serine and threonine residues, and the site of this interac-
tion maps to the region in KAPP that contains the FHA
domain [19]. By analogy, NBS1 might therefore interact
with a phosphoprotein in the DNA repair apparatus.
The function of NBS1
NBS1 was found to have a role in DNA repair virtually at
the same time as the cloning of the NBS1 gene when
Carney et al. [12] discovered that the gene encoding p95, a
component of the human Mre11–Rad50-containing DNA
repair complex, was identical to NBS1. The MRE11 and
RAD50 genes were originally identified from mutations in
the budding yeast Saccharomyces cerevisiae that cause
hypersensitivity to ionizing radiation and an inability to
initiate and/or complete meiosis [20]. Both gene products
are involved in repairing DNA double-strand breaks
formed by ionizing radiation, and in the initiation and pro-
cessing of DNA double-strand breaks in meiotic recombi-
nation [21]. Rad50p and Mre11p appear to be homologues
of the Escherichia coli proteins SbcC and SbcD, respec-
tively [22], which together have DNA exonuclease and
endonuclease activity [23], suggesting that Mre11p and
Rad50p might also have these activities. 
Carney et al. [12] isolated a complex from human cells that
contained hMre11, hRad50 and several other polypep-
tides. They obtained sequence information for a copurify-
ing polypeptide of 95 kDa — p95 — and used it to
construct a cDNA from overlapping expressed sequence
tags in the human genome database and to predict the
amino acid sequence of p95. The gene encoding p95 was
localized to chromosome 8q21.3 indicating that it was
probably the gene defective in NBS patients that had
been mapped to this location the previous year. The
recent sequencing of the NBS1 gene [9,10] verified that
NBS1 was identical to the gene encoding p95 [12].
Further confirmation was provided by the finding that the
p95 protein and its mRNA are absent from NBS cells [12].
Carney and colleagues found that  NBS1 binds to hMre11
in a yeast two-hybrid protein–protein interaction screen.
Together with hMre11, hRad50 and possibly other
polypeptides, NBS1 forms a complex with an estimated
molecular mass of 1600 kDa [12]. NBS1 is not required for
the interaction between hMre11 and hRad50, but it does
seem to be required for the subcellular relocation of these
proteins in response to DNA damage. Before treatment of
cells with ionizing radiation, both hMre11 and hRad50 are
distributed diffusely throughout the nucleoplasm, pre-
sumably in a complex. After irradiation, however, hMre11
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Figure 1
The domain structure of NBS1 is shown
diagrammatically. It comprises adjacent FHA
and BRCT domains spanning the amino-
terminal 200 amino acids of the polypeptide
and a 550 amino acid tail with no apparent
homology to other proteins. In general, FHA
domains are 55–75 amino acids in size with
indistinct boundaries. They contain three
highly conserved blocks (blue) that are
predicted to form β strands, separated by
more divergent spacer sequences. The only
invariant residues are a glycine–arginine pair
(GR) in the first block and a histidine (H) in
the second. The FHA domain is distinct from
the forkhead domain (FD) that is also found in
the forkhead family of transcription factors.
BRCT domains are about 95 residues long
and comprise five highly conserved blocks
(yellow) designated A–E. The only invariant
residue is a tryptophan (W) in block D. The
two residues at the end of block B are
frequently G or A. The domain is predicted to
contain four β strands, probably forming a
core sheet structure, and two α helices. The
arrow indicates the location of the common
founder mutation in NBS patients (657del5).
N FHA
55–75
~95
A B
G/A W
C D E
657del5
Current Biology   
C
750
HGR
BRCT
R624 Current Biology, Vol 8 No 17
and hRad50 are found in foci within the nucleus [24].
These foci may be individual sites of double-strand breaks
in the DNA or they may correspond to subnuclear struc-
tures that somehow organize the DNA repair machinery.
By contrast, these foci of hMre11 and hRad50 do not
appear in response to ionizing radiation in cells that lack
NBS1. Formation of the foci is also drastically reduced in
AT cells [24], suggesting that ATM might recruit the
hMre11–hRad50 complex to the double-strand break or
trigger signalling pathways that result in the relocation of
the complex.
In S. cerevisiae, Mre11p and Rad50p form a complex with
at least one other protein (of approximately 95 kDa),
Xrs2p, which is also involved in repairing double-strand
DNA breaks [20]. In the human complex, the p95 protein
— which is now known to be NBS1 — was interesting at
first because of its similarity in size to Xrs2p, indicating
that it might be the human homologue of this protein.
Surprisingly, the sequences of the two proteins are rela-
tively dissimilar, having a sequence identity of 28% only
over their first 115 amino acid residues. No other protein
encoded in the yeast genome appears to be a closer rela-
tive of NBS1, however, so NBS1 might be a functional
analogue or a distantly related homologue of Xrs2p.
A model for the function of the NBS1–Mre11–Rad50
complex
How then might NBS1 function? From its association with
hMre11 and hRad50, and its similarity with Xrs2p, it
seems likely that NBS1 will function in the recognition,
repair and/or signalling of DNA double-strand breaks.
Breaks that form in response to DNA-damaging agents,
such as ionizing radiation, might be recognized directly by
NBS1 or, more likely, NBS1 might recognize a signal from
a DNA-break-detecting complex, which may contain
DNA–PK and/or ATM (Figure 2). By analogy with the
Arabidopsis protein KAPP, this signal might be phosphory-
lation on a serine or threonine residue in a target protein
that would then be recognized by the FHA domain in
NBS1. Alternatively, other protein–protein interactions
might be involved, for example through the BRCT
domain in NBS1. In binding to a component at the
double-strand break, NBS1 might act as an adaptor bring-
ing the Mre11–Rad50 exonuclease activity to the DNA
ends to prepare them for ligation. In doing so, it may also
recruit other components in the complex to facilitate the
repair process. Because NBS cells are defective in the
control of cell-cycle checkpoints [4,5], NBS1 itself, or the
consequences of its action, must also impinge on the
DNA-damage signalling pathways to induce a delay in
DNA replication.
Towards a molecular explanation of NBS
This new knowledge of the NBS1 gene and the role of its
product in the complex containing hMre11 and hRad50
suggest how the cellular phenotypes of NBS cells might
arise. Certain features of NBS, including chromosomal
instability, sensitivity to DNA-damaging agents and failure
to induce checkpoint controls, might be explained by the
absence of a protein that is crucial for recognizing, sig-
nalling and repairing DNA double-strand breaks. The clin-
ical symptoms of immunodeficiency might be explained if
there are defects in the essential gene rearrangements that
Figure 2
A model for the function of the NBS1 protein.
NBS1 is part of a ~1600 kDa complex that
contains hMre11, hRad50 and, most likely,
other proteins. When double-strand breaks
occur in the DNA, for example upon treatment
with ionizing radiation or with radiomimetic
drugs such as bleomycin, they are most
probably recognized by a complex of proteins
that may include, or interact with, ATM or
DNA–PK. One of these kinases may then
phosphorylate a substrate in the complex that
provides a recognition site for the
NBS1–hMre11–hRad50 complex, and/or
some other type of protein–protein interaction
may occur, causing the relocalization of the
complex from diffuse points in the nucleus to
foci of DNA repair. The recruited
NBS1–hMre11–hRad50 complex may then
promote repair, for example by exonuclease
action on the DNA ends, and may also signal
to the cell-cycle checkpoint machinery, for
example to prevent p53 turnover thereby
increasing the cellular levels of p53.
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generate the immunoglobulin and T-cell receptor reper-
toire or that are involved in the switching of immunoglobu-
lin isotypes. The predisposition to malignancy, especially
in lymphoid cells, might be explained by the accumulation
of unrepaired chromosomal damage, leading to the dele-
tions and translocations typical of tumorigenesis. Finally,
the frequent occurrence and compromised repair of chro-
mosomal damage might make the cells of NBS patients
grow more slowly, or cause them to undergo apoptosis
more frequently, possibly producing the developmental
defects typical of NBS — microcephaly and growth retar-
dation. Given that Mre11 is essential for mouse embryonic
stem cell viability [25], it will be interesting to know
whether the NBS1–Mre11–Rad50 complex also performs
other roles in embryonic and foetal development.
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